Corporate Governance

Read about the Paxman Board of Directors, the Management Team and their backgrounds and experience. You can also find information on the nominating committee, Annual General Meeting and regulatory documentation.
Board of Directors
The Management
Nominating Committee
Annual General Meetings
The Auditors
Regulatory Documents
Board of Directors
Introducing the Paxman Board of Directors – here you will find information on their knowledge and experience as well as their qualifications, shareholdings, warrants held and dependence.
Per-Anders Johansson
Chairman of the Board
Board member since 1 Dec 2016
Per-Anders Johansson
has extensive experience
from technology and
development companies
and is an active investor
through CIMON AB.
CIMON AB has invested
in and developed several
successful companies. PerAnders Johansson also has
long industrial experience
from the Karlshamns group,
Nordico and Ellos where he
has held leading positions.
Qualifications
Mechanical engineer, specialized in process technology.
Shareholding
29 880 shares privately, 941,809 shares through CIMON Venture Trust AB and 310,000 shares through NOMIC AB.
Dependence
Yes. Dependence in relation to CIMON Venture Trust AB, independent of company.
Glenn Paxman
Board Member
Board member since 20 Dec 2016
Glenn Paxman is the
founder of Paxman and
responsible for the design
and development of the
scalp cooler. He has over
40 years of business
experience including
management strategy and
product design of medtech
products, and over 25 years
of experience in developing
manufacturing processes
for the pharmaceutical and
chemical industry sectors.
Glenn is also the founder
and chairman of Brewfitt
Ltd. Currently, his role in
the company is to support
the board and management
in strategic matters and
assist in growth-stimulating
projects on the American
market.
Qualifications
Mechanical engineer in process technology, specialized in manufacturing technology.
Shareholding
2 506 386 shares
Dependence
Yes, in his capacity of major shareholder.
Björn Littorin
Board Member
Board member since 1 Dec 2016
Björn Littorin has
extensive experience as a
management consultant,
business leader and
board member of both
manufacturing and servicebased companies as well
as 20 years’ experience
as Investment Manager
and board member
of technology and
development companies,
mostly within medical
technology. Some of the
companies where he
has been CEO or board
member have been listed
on the Stockholm Stock
Exchange. He has also been
a board member of Paxman
Group Ltd and its subsidiary
Paxman Coolers Ltd since
2001.
Qualifications
MSc of Engineering from Chalmers University of Technology.
Shareholding
347 865 shares
Dependence
Independent in relation to the company and its management as well as major shareholders.
Robert Kelly
Board Member
Board member since 1 Dec 2016
Born 1961. Robert Kelly is an attorney specialized in corporate law but is also an authorized public accountant. Robert Kelly has extensive experience of business management in both private and public companies such as Minorplanet Systems plc, Caudwell Group and Kunick plc. Up to 2016 Robert Kelly was Managing Partner of Armitage Sykes Solicitors Limited. He managed the sale of Armitage Sykes to Schofield Sweeney LLP where he remained a corporate partner for 7 years before joining Holden Smith Law. He is a member of the audit committee of Huddersfield University.
Qualifications
M.A. from Oxford University, Graduate Diploma in Law from Huddersfield University, Legal Practice Course from College of Law in York.
Shareholding
33 212 shares
Dependence
Independent in relation to the company and its management as well as major shareholders.
Maria Bech
Board Member
Board member since 1 Dec 2016
Maria Bech has extensive
experience from several
companies in the biotech
and pharmaceutical sector.
She has held leading
positions including Clinical
Project Manager and
Study Delivery Director
at AstraZeneca, Director
Clinical Operations and
Principal Project Manager
at Karo Bio AB, and
Chief Scientific Officer
at Smartfish AB. Maria
is a board member in
Neuronano AB and Hoseth
Biocare AS, and CEO in
EpiEndo Pharmaceuticals.
Qualifications
Master of Science in molecular biology
Shareholding
8,700 shares
Dependence
Independent in relation to the company and its management as well as major shareholders.
Richard Paxman, OBE
CEO
Board member since 1 Dec 2016
Richard Paxman has
extensive experience from
global market development,
including design of clinical
studies and regulatory
approvals specifically
related to scalp cooling.
He has worked for the
company since 2009.
Before Richard Paxman
started his assignment at
Paxman Coolers Ltd., he
held a leading position at
Brewfitt Ltd.
Qualifications
Management Science at University of Manchester, Institute of Science and Technology
Shareholding
1,281,000 shares
Dependence
Yes, in his capacity of major shareholder.
Karen Clakeley
Board Member
Board member since 23 May 2024
Born in 1960. Karen has over 35 years of experience as a senior sales executive and turnaround leader, with experience working in sales strategy, customer experience, marketing, product management and organizational development. Karen serves as VP of Sales for EasyVote Solutions. Previously, Karen held the position of Executive Director of Market Development at Hart InterCivic, Vice President of North American Sales at Everyone Counts, and managed a portfolio of over $170 million at DST Systems.

Qualifications
BA in Public Administration from San Diego State University, Certificate of Marketing Communications from University of California in Los Angeles.
Shareholding
25,256 shares
Dependence
Independent in relation to the company and its management as well as major shareholders.
The Management
Introducing the Paxman Management Team – here you will find information on their career experience, responsibilities within the business, qualifications, shareholdings and warrants held.
Richard Paxman, OBE
CEO
Born 1983, employed since 2009. Richard Paxman has extensive experience in global market development including clinical trial design and regulatory approvals specifically related to scalp cooling. Richard Paxman has been active within the business since 2007, and has also held a management role for Brewfitt Ltd prior to his engagement in Paxman. Richard Paxman is a board member of Brewfitt Ltd and Paxman Coolers Ltd.

Awarded the OBE for services to international trade in the King’s first Birthday Honours List in June 2023, Richard is passionate about international trade and promoting the UK overseas.

Richard is also a private sector member of the Business Economy Innovation Committee (BEIC) for the West Yorkshire Combined Authority (WYCA) as well as Chair of the WYCA HealthTech Cluster. He participates as a Medilink North of England Advisory Group Member. 
Qualifications
Management Science at University of Manchester, Institute of Science and Technology
Shareholding
1,282,880 shares
Emelie Gustafsson
CFO
Born 1980, employed since 1 March 2020. Emelie Gustafsson has been the C.F.O. of the entire CIMON Group since 2015, and is a Board member of a large number of companies within this Group. She is also the Investor Relations manager. in Skolon AB (Publ.)
Qualifications
University studies in business administration and tax law (University of Kristianstad)
Shareholding
4,140 shares
Claire Paxman
Brand Ambassador & Director of Global
Training
Born 1978, employed since 2010. Claire has fulfilled many roles within the company, initially implementing training for UK hospitals.  This led to a business development and sales role, becoming a member of management since 2012 followed by becoming Director of Sales & Training followed by her current role as Brand Ambassador and Director of Global Training.  Claire joined the Senior Leadership Team in 2019.

Claire Paxman’s key responsibilities are leading on the development, implementation and management of global training and certification programmes to educate and support clinicians to adhere to best practice protocols. She also manages the company’s usability operations side of the business, particularly in relation to the treatment operational protocols.

Claire is instrumental in developing key partnerships with stakeholders and charities whilst identifying novel and strategic initiatives to drive global awareness.  Claire also represents the business on various platforms within her role of Brand Ambassador.
Qualifications
Huddersfield Technical College
Shareholding
0 shares
Number of warrants held
20,000
Karin Buck
VP of US Operations
Employed since 2017, member of management since 2017 and joined Senior Leadership Team in 2019. One of the first US employees, Karin Buck brought exceptional experience in business, marketing, customer service and growing brands when joining the Company. Day to day duties include managing the growing US employees, building relationships with the Doctors, Nurses and all the Healthcare Providers at hospitals and medical offices and increasing the awareness of scalp cooling in the US by engaging with advocacy groups as well as advertising and marketing programs. Karin has been pivotal in the implementation and adoption of the company’s new buy and bill model driving utilisation and business growth.
Qualifications
Temple University, Journalism
Shareholding
0 shares
Number of warrants held
0
Emma Thornhill
Group Finance Director
Born 1985, employed since 2017, member of management since 2017 and joined Senior Leadership Team in 2019. Emma Thornhill’s key responsibilities include the managing the finance department, responsible for finance activities of all trading entities, which includes the UK, US and Canada, preparing all financial reporting, budgeting, and planning. Emma is also responsible for all audit and compliance of the financial statements. Emma works closely with the company C.F.O. in preparation of quarterly and annual reports. Emma historically worked in practice at a top 10 UK accountancy firm for 10 years.
Qualifications
FCA Qualified Accountant, BA (Hons) Accounting
Shareholding
2,186 shares
Number of warrants held
20,000
Patrick Burke
Head of Research & Development
Born 1959, employed since 2009. Member of management since 2015, joined Senior Leadership Team in 2019. Pat has fulfilled many roles within the company including regulatory, operations and R & D. Current area of responsibility is R&D. Pat brings to the company a vast experience from industries and is a key mentor within the business.
Qualifications
Ordinary National Electrical Engineering, Higher National in Electronics and Computing, B.Ed. Design and BSc (Hons) Applied Mathematics
Shareholding
0 shares
Number of warrants held
20,000
Alexandra Sheldrake
Head of Quality & Regulatory Affairs
(Management Representative PRRC)
Born 1985, employed since 2009. Member of management since 2016, joined Senior Leadership Team in 2019. Within her capacity as Head of Quality and Operations Alexandra ensures compliance with global regulatory requirements including MDR and MDSAP, ensures that the requirements of the quality management system and technical files have been effectively defined, documented, implemented, and maintained, and is responsible for all new and existing product registrations worldwide. In addition supports clinical trials where appliable. In her capacity as Head of Operations, Alexandra develops and manages the deployment of PAXMAN Operations strategy, including production purchasing and US servicing.
Qualifications
Level 2 and 3, Business Administration
Shareholding
0 shares
Number of warrants held
20,000
Louise Aspey-Smith
Head of Brand and Marketing
Employed and a member of management and the Senior Leadership Team since 2024. Louise is an accomplished and versatile marketing professional, with a proven record of developing and executing impactful marketing strategies and meaningful content to meet commercial targets within the med-tech and healthcare industry. She has experience in operating at global level, within EMEA and regionally for the UK, for large multinationals, SME's and start-up organisations.
Louise’s key responsibilities include: the development and management of the Paxman marketing and communication strategy, generating and executing engaging omni-channel campaigns, shaping and elevating the Paxman brand to ensure a positive patient experience, delivering external and internal communications, and leading the Paxman Marketing team.
Qualifications
BA (Hons) Business & Marketing at Manchester Metropolitan University
Shareholding
0 shares
Number of warrants held
10,000
Stuart Rowling
Head of UK Sales & Training
Born 1982, employed since 2015. Member of management since 2018, joined Senior Leadership Team in 2019. His responsibilities include the management of UK and Ireland Training Specialists and overseeing all UK and Ireland sales. Wider duties include account management of all UK private health care providers, implementation of UK and Ireland sales strategies and control of our home health care provision.
Qualifications
NVQ2- Sport, Recreation and Allied Occupations- Sports Leadership Advanced BTEC National Diploma – Sport and Leisure Studies and ILM level 7
Shareholding
367 shares
Number of warrants held
20,000
Anna Parker
Head of International Sales
Born in 1983, employed since 2017, joined Senior Leadership Team in 2019. Anna’s focus is to continue the mobilisation of Paxman’s global network of distributors to improve the accessibility of scalp cooling. Anna manages the international team based in the UK as well as overseas staff deployed in India, Scandinavia, France and Spain.
Qualifications
International Business Management (MSc), English Studies (MA), Marketing Management (BSc)
Shareholding
0 shares
Number of warrants held
20,000
Liza Hirst
EA to CEO / Head of HR
Born 1974, employed since 1994, joined Senior Leadership Team in 2019
The key responsibilities include direct liaison with CEO on all business activities including contracting, logistics, travel, diary management and scheduling. The responsibilities also include close working relationships with Head of Finance and US of VP Operations. HR function including contract preparation, onboarding, liaison with HR/Employment Law consultants.
Qualifications
North of England Higher Secretarial College Diploma
Shareholding
9,393 shares
Number of warrants held
20,000
Nominating Committee
For the 2026 AGM, the following members have been appointed to the Nominating Committee:
Roger Johansson
Committee Chairman representing Per-Anders Johansson
Email roger.johansson@mhmail.se

Tel +46 793- 573 543

Glenn Paxman
Board member and majority shareholder.
Email GlennPaxman@brewfitt.com
Tel +44 7768 795 809
Tom Elliott
Representing Richard Paxman

Email     t.elliott@medilink.co.uk

Tel         +44 7772 519 525

Shareholders may also contact the Nominating Committee by ordinary mail, sent to PAXMAN AB (publ), “Nominating Committee”, Pirgatan 13, SE-374 35 KARLSHAMN, Sweden.

The principles on which the appointment of the committee members is based, as well as the Charter for the committee’s work, are available here.
Annual General Meetings
Here you will find summaries of the Annual General Meetings, held in May each year, and links to the minutes taken at each meeting.
Press release from PAXMAN AB’s 2025 Annual General Meeting
PAXMAN´s AGM was held today, 16 May 2025, at NetPort in Karlshamn. Almost 51,7 % of all issued shares were...
Read Article →
Press release from the Extra General Meeting of Paxman AB (publ)
PAXMAN´s EGM was held today in Karlshamn. Almost 53,35 % of all issued shares were represented at the meeting. Paxman...
Read Article →
Press release from PAXMAN AB’s 2024 Annual General Meeting
PAXMAN´s AGM was held today, 23 May 2024, at NetPort in Karlshamn. Almost 55,4 % of all issued shares were...
Read Article →
Press release from PAXMAN AB’s 2023 Annual General Meeting
PAXMAN´s AGM was held today, 24 May 2023, at NetPort in Karlshamn. Almost 57 % of all issued shares were...
Read Article →
Press release from PAXMAN AB’s 2022 Annual General Meeting
PAXMAN´s AGM was held today, 25 May 2022, at NetPort in Karlshamn. Almost 51 % of all issued shares were...
Read Article →
Press release from PAXMAN AB’s 2021 Annual General Meeting
PAXMAN´s AGM was held today, 26 May 2021, at NetPort in Karlshamn. Almost 53 % of all issued shares were...
Read Article →
Press release from PAXMAN AB’s 2020 Annual General Meeting
PAXMAN´s second AGM was held today, 27 May 2020, at NetPort in Karlshamn. Almost 64 % of all issued shares...
Read Article →
Press release from PAXMAN AB’s 2019 Annual General Meeting
PAXMAN’s second AGM was held today, 23 May 2019, at NetPort in Karlshamn. Slightly more than 72 % of all...
Read Article →
The Auditors
Auditor for the Swedish parent company is the registered public accounting firm Ernst & Young Aktiebolag, with Henrik Rosengren as auditor in charge.
Ernst & Young Aktiebolag

Drottninggatan 54
371 33 Karlskrona
Office +46 455 30 91 00
https://www.ey.com/en_gl

Auditor for the UK subsidiaries is:
Forrester Boyd Robson Limited

Suite 606 West Village

114 Wellington Street

Leeds

LS1 1BA

 

What we do
Paxman are world leaders in chemotherapy side effect management on an ambitious journey to change the face of cancer through cryotherapy-based treatments. The Paxman mission is to democratise access to scalp cooling globally.
Learn more →
Financial Information
Read the latest Paxman financial reports. In these comprehensive documents, you will find a detailed overview of our financial performance, key milestones, and a strategic outlook for the future. Reports are published quarterly and annually.
Read reports  →
Investing in Paxman
Paxman has treated 100,000+ patients and installed 5,000+ systems in more than 65 countries worldwide. We are helping to manage the trauma of chemotherapy hair loss. By investing in Paxman, you're not just supporting a company; you're joining us in changing the face of cancer.
Visit the Investor Centre →
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram